Clinical trial
Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases…
NCT00003907 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003907 |
|---|---|
| Title | Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver |
| Official title | Chemoembolization in Hepatocellular Carcinoma or Neuroendocrine Hepatic Metastases: A Phase II Multi-Center Trial |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Liver Cancer, Metastatic Cancer |
| Intervention type | Drug, Procedure |
| Interventions | cisplatin, doxorubicin, mitomycin, embolization |
| Enrollment | 50 |
| Start date | Dec 15, 1999 |
| Primary completion | May 1, 2011 |
| Completion | Aug 1, 2012 |
| First posted | Oct 9, 2003 |
| Last update posted | Jul 5, 2023 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: